Teva Pharmaceutical Industries (TEVA)
Add to Watchlists Create an Alert
39.34
-0.15 -0.38%
NYSE
May 24, 8:00PM
BATS Real time
Currency in USD
Teva Pharmaceutical Industries Accounts Receivable:
5.416B for March 31, 2013Teva Pharmaceutical Industries Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 5.416B |
| Dec. 31, 2012 | 5.572B |
| Sept. 30, 2012 | 5.782B |
| June 30, 2012 | 5.43B |
| March 31, 2012 | 6.056B |
| Dec. 31, 2011 | 6.213B |
| Sept. 30, 2011 | 5.605B |
| June 30, 2011 | 5.469B |
| March 31, 2011 | 5.576B |
| Dec. 31, 2010 | 5.476B |
| Sept. 30, 2010 | 5.228B |
| June 30, 2010 | 4.985B |
| March 31, 2010 | 5.136B |
| Dec. 31, 2009 | 5.019B |
| Sept. 30, 2009 | 4.689B |
| June 30, 2009 | 4.376B |
| March 31, 2009 | 4.134B |
| Dec. 31, 2008 | 4.653B |
| Sept. 30, 2008 | 3.916B |
| June 30, 2008 | 3.784B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
TEVA Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Pfizer | 12.74B |
| Mylan | 1.514B |
| Alexza Pharmaceuticals |
TEVA Accounts Receivable Rankings
| Overall |
99th percentile 75 of 7600 |
| Sector |
99th percentile 6 of 653 in Healthcare |
| Industry |
98th percentile 1 of 66 in Drug Manufacturers - Specialty & Generic |
TEVA Accounts Receivable Range, Past 5 Years
| Minimum | 3.784B | Jun 2008 |
| Maximum | 6.213B | Dec 2011 |
| Average | 5.126B |